2022 Virtual SNMMI Mid-Winter and ACNM Annual Meeting

Emerging technologies, the latest clinical applications, best practices, and more are waiting for you. The 2022 Virtual SNMMI Mid-Winter and ACNM Annual Meeting will feature three educational tracks highlighting the latest innovations and techniques in the field, including a dedicated track on cardiovascular nuclear medicine.

Meeting website | Educational Program | Exhibits | Register

Unfortunately, the ongoing COVID-19 global pandemic and surging Omicron variant have forced us to cancel our planned in-person event in Orlando. We are excited to announce that a Virtual 2022 SNMMI Mid-Winter and ACNM Annual Meeting will now take place Friday, February 25 through Sunday, February 27, 2022. Read the full announcement.

SNMMI Therapeutics Conference

Make your plans to attend the SNMMI Therapeutics Conference, in-person, March 10-12, 2022 at the Hyatt Regency New Orleans. This two-and-a-half-day event will explore the latest innovations and clinical applications in radiopharmaceutical therapy.

Meeting website | Educational Program | Exhibits | Hotel | Register

Early-bird registration deadline: Thursday, January 20, 2022

SNMMI 2022 Annual Meeting

Make 2022 the year you take the next important step in your career path. Submit your abstract by Tuesday, January 11, 2022, for the opportunity to present and publish innovative scientific investigations to a global audience of medical imaging professionals at the SNMMI 2022 Annual Meeting, June 11-14, 2022 in Vancouver, BC, Canada. 

Meeting website | Submit your Abstract

Due to the surging Omicron variant, we have made the decision to provide you with more time to submit your abstract for the SNMMI 2022 Annual Meeting.
You now have until Tuesday, January 25, 2022, to submit your abstract for the opportunity to present your research in Vancouver or virtually.

Coding and Reimbursement

The most up-to-date and comprehensive source for nuclear medicine coding and reimbursement information on the web. Please note that ALL information and materials within the SNMMI Coding Corner are direct products of the SNMMI Coding and Reimbursement Working Group.

For Hospitals (APCs, IPPS) Find general coding and reimbursement information for hospitals.

For Private Practices (RBRVS) Find general coding and reimbursement information for professionals in private practices.

Coding and Reimbursement Q&A This easy to use feature contains over 100 questions and answers related to topics such as cardiac, endocrine, neurology, nuclear medicine-related drugs, oncology, PET, PET/CT, radiopharmaceuticals, and more!

Dose Optimization

In nuclear medicine and molecular imaging, small amounts of radioactive agents are administered to the patient to allow the physician to examine molecular processes within the body. These procedures are highly effective, safe and painless diagnostic tools that present physicians with a detailed view of what’s going on inside an individual’s body at the cellular level. For more than 60 years, these studies have been used to evaluate practically all systems within the body, including the heart and brain, as well as to image many types of cancer.

SNMMI has a large body of knowledge in dose optimization that is continually growing and developing. The dose optimization website presents a wide variety of resources, including SNMMI journal articles, educational offerings, media-related information, links to useful websites and more.

Guidelines

The practice guidelines help to identify those elements of the procedure that are most important in obtaining a high-quality examination, while simultaneously controlling costs. Use of standardized procedures will increase the applicability of clinical research among multiple institutions, in turn, increasing the value of research studies, particularly in the field of technology assessment. In the interest of creating strong, comprehensive documents, some guidelines were formally adopted by SNMMI in collaboration with other professional organizations.

View Guidelines.

Focusing on the Future of Molecular Imaging

SNMMI's Center for Molecular Imaging Innovation and Translation is an organizational component within the SNMMI that is dedicated to all aspects of molecular imaging in the detection and management of disease. The center is currently facilitating initiatives to bring molecular imaging discoveries from the lab to the patient and to advance "personalized" medicine.

Access resources.

The Clinical Trials Network’s mission is to advance the use of molecular imaging radiopharmaceuticals in clinical trials through standardization of chemistry and imaging methodology. This includes using imaging radiopharmaceuticals during the course of drug development, as well as bringing new agents to regulatory approval. Click here to learn more about the CTN’s Oncology and Neurology Scanner Validation programs, ongoing efforts to harmonize reconstruction parameters in oncology clinical trials, and other services that CTN offers to help scientists advance their research.

Educational Offerings

SNMMI educational programs are designed to meet the professional development needs of scientists involved in nuclear medicine and molecular imaging endeavors. 

Visit the SNMMI Learning Center.

Additional Resources

• SNMMI 2018 Virtual Meeting
• SNMMI 2018 Virtual Poster Hall
• Commission on Accreditation of Medical Physics Educational Programs, Inc. (CAMPEP)
• CME Gateway
• American Association of Physicists in Medicine (AAPM)